RFK Jr., a prominent vaccine skeptic, wants to make many changes to the U.S. food and drug system as head of the HHS. Here's ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK ...

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

Fear is spreading across healthcare stocks after news emerged that President-elect Donald Trump will nominate vaccine skeptic ...

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Shares in vaccine makers and healthcare firms around the world slid sharply on Friday, as investors warned that Donald ...

FLORIDA: President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr, an environmental activist who ...